|
|
Attorney Profiles
Jeffrey Pepe, PhD.
Jeff is a patent attorney with over 12 years of experience working at both law firms and companies. As in‑house counsel, Jeff was chief intellectual property officer at two life science companies. Jeff has expertise in worldwide patent matters, including strategic planning, competitive analysis, due diligence, patent procurement, licensing, and enforcement.
Experience
- Developing, implementing, and coordinating worldwide patent portfolio strategies to match client business goals, including patent life cycle management;
- Managing and directing worldwide trademark portfolio development, as well as successfully negotiating settlement and/or co-existence agreements;
- Preparation of clearance opinions and landscape reports; European opposition proceedings and appeals, patent reexaminations, and enforcement;
- Performing due diligence reviews of patent estates for corporate transactions and financings;
- Reviewing and negotiating intellectual property provisions of license, manufacturing, collaboration, clinical trial agreements, confidentiality agreements, material transfer agreements, consulting agreements, and feasibility agreements;
- Working with legal teams that successfully negotiated and completed multi-million dollar deals (1) to out-license intellectual property-related assets and (2) in company sale/acquisition, including licensing and sale of intellectual property;
- Establishing and managing intellectual property budgets, as well as managing outside counsel and partner/alliance relationships.
Professional Activities
- Adjunct Law Professor, Seattle University School of Law
Presentations
- Presenter, "From Laboratory to Law: Understanding Intellectual Property," Seattle University Intellectual Property Law Society, Seattle, Washington, 2003
- Presenter, "Special Issues Relating to Biotechnology Patents," Law Seminars International, Seattle, Washington, 2005
- Presenter, "Advanced Biotechnology Prosecution Issues: Some Case Studies," Fred Hutchinson Cancer Research Center, Seattle, Washington, 2005
- Panelist, "Freedom to Operate: Overcoming Obstacles by Ensuring that the Purchaser/Licensee Has the Right to Commercialize the IP at Issue," American Conference Institute Conference on Life Sciences IP Due Diligence, New York, New York, 2010
- Panelist, "Antibodies: Overcoming Patentability Hurdles and Claim Drafting Strategies for New Technological Development," American Conference Institute Conference on Biotech Patents, Boston, Massachusetts, 2010
- Panelist, "New Takes on Obviousness: Pre-Suit Considerations for Brand-Names and Generics," American Conference Institute Conference on Paragraph IV Disputes, San Francisco, California, 2010
- Presenter, "Patent and Regulatory Law: The Good, The Bad, and The Ugly," Organization of Regulatory and Clinical Associates (ORCA), Bellevue, Washington, 2011
Education
- UCLA, Ph.D., 1993, Microbiology and Molecular Genetics
- Seattle University School of Law, J.D., 2000
Professional Memberships and Certifications
|
